Early trial data and government refusal to approve the shot for over-65s, despite mounting evidence that it works well, have led to thousands of doses going unused. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.